MiniMed Group (NASDAQGS: MMED) has seen its one-year price target revised to $26.24 per share, effective September 15, 2026, representing a 20.43% increase from the previous estimate of $21.79 on August 25, 2026. The updated price targets range from a low of $21.21 to a high of $29.40, reflecting an average price target that is 19.23% higher than its most recent closing price of $22.01 on September 14, 2026.
MiniMed Group’s analyst recommendations exhibit a positive trend, with 88.9% of 18 total recommendations being positive as of September 1, 2026. Recent earnings reported on September 1 showed an actual EPS of 0 against an estimate of 0.0952, with reported revenue of $843 million, slightly below the estimated $843.6 million.
The building products sub-industry is witnessing diverse target revisions, with 17 out of 34 companies seeing raised targets. Overall, the peer group showed varied target revisions, with AtaiBeckley down by -7.93% and GH Research up by +6.65%.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
